| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |